New research led by a University of Wisconsin–Madison assistant professor could shed some light on whether toxic metals commonly found in and around the home could impact an older dog’s vision and overall health.
vision research
Can precision medicine treat childhood blindness?
Using stem cells, gene therapy to correct errors in retinal cells A research team at the University of Wisconsin School of Medicine and Public Health has shown that two novel approaches to treating an inherited …
Biomanufacturing projects stepping out at UW-Madison
Human skin cells (pink) migrating upon a medical device (green) that was manufactured from a parsley leaf. Plant-derived devices are being developed into implants for surgical wound healing with help from the Forward BIO Institute. GIANLUCA …
Vision Driven. The Chad Mayfield Story.
If you’d had the good fortune to know Chad Mayfield as a kid, you’d have thought it quite reasonable, even probable, that he would grow up to play third base in the big leagues …
It’s a Go – The Clinical Trials Unit Embarks on the First Human Gene Therapy Trial in DOVS History
The University of Wisconsin-Madison Department of Ophthalmology and Visual Sciences (DOVS) has formally been announced as a partner site for Nightstar Therapeutics’ STAR Phase 3 Registrational Trial for NSR-REP1 in Choroideremia. This is the first …
Winners Never Quit: Meet Mia Zutter
Mia Zutter, a former patient at the Department of Ophthalmology and Visual Sciences, has had an amazing journey from receiving a devastating diagnosis to achieving a Paralympic dream. Mia had wanted to excel in sports …
Improving Glaucoma Treatment // Experimental Gene Transfer Techniques
Listen to Full Interview In an interview with WYPL-FM’s (Memphis, TN) radio show Eye on Vision, Curtis Brandt, PhD, professor of ophthalmology and visual sciences, discussed the research of experimental gene transfer techniques to …
AREDS2
Age-Related Eye Disease Study 2 (AREDS2) 10-Year Follow-On Study
Zoster Eye Disease Study (ZEDS)
A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Suppressive Valacyclovir for One Year in Immunocompetent Study Participants with an Episode of Dendriform Epithelial Keratitis, Stromal Keratitis, Endothelial Keratitis, and/or Iritis Due to Herpes Zoster Ophthalmicus (HZO) in the Year Prior to Enrollment (ZEDS)